Real-World Apremilast Use for Treatment of Plaque Psoriasis in Italy: Patient Perspective, Characteristics, and Clinical Outcomes from the DARWIN StudyClaudia Giofrè, Sara Rizzoli, Aurora Parodi et al.|Advances in Therapy|2023Cited by 2
Real-world effectiveness and safety of guselkumab in adult patients with facial and/or genital psoriasis: a 52-week analysis from the Italian multicentric GULLIVER studyC. Bonifati, Antonio Costanzo, G. Argenziano et al.|Journal of Dermatological Treatment|2026Cited by 1
Psychological Well-Being of Patients with Moderate-to-Severe Plaque Psoriasis Treated with Tildrakizumab: 28-Week Interim Results from a Multicenter Observational Study in Italy Using the DASS-21 Questionnaire, the BLUE StudyE. Trovato, Antonio Costanzo, Claudio Bonifati et al.|Dermatology and Therapy|2026Cited by 1
Real-world effectiveness and safety of guselkumab in adult patients with facial and/or genital psoriasis: a 52-week analysis from the Italian multicentric GULLIVER studyClaudio Bonifati, Antonio Costanzo, Giuseppe Argenziano et al.|Open MIND|2026Cited by 0
Real-world effectiveness and safety of guselkumab in adult patients with facial and/or genital psoriasis: a 52-week analysis from the Italian multicentric GULLIVER studyClaudio Bonifati, Antonio Costanzo, Giuseppe Argenziano et al.|Figshare|2026Cited by 0